This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Dr. Alen Salerian, Well-Known D.C. Psychiatrist, Invites Public Debate On Treatment Of Patients With Mental And Physical Pain

WASHINGTON, July 1, 2013 /PRNewswire/ -- The District of Columbia Board of Medicine today published an Opinion revoking the medical license of a well-known psychiatrist, Dr. Alen J. Salerian.  The Board has determined that Dr. Salerian's prescriptions of certain narcotics in certain dosages fell outside the relevant standard of care. 

David Sanford of Sanford Heisler, LLP in Washington, D.C., said that "Dr. Salerian will appeal the Board of Medicine decision and we are confident that the D.C. Court of Appeals will overturn it."

Dr. Salerian has been a tireless advocate during his nearly 40-year career for improving the quality of life for his mental health and pain patients.  Dr. Salerian received his license to practice medicine in the District in 1974, completing his psychiatric residency as Chief Resident at GW in 1976 and serving as an Assistant Clinical Professor at GW for 26 years.  Dr. Salerian also worked at the Psychiatric Institute of Washington as the Chair of the Patient Care Evaluation Committee; as an Associate Medical Director; and as investigator for the Clinical Trial Unit.  Most recently, Dr. Salerian founded and practiced as a psychiatrist at the Salerian Center for Neuroscience and Pain to treat those with pain and psychiatric illnesses.

Dr. Salerian founded the non-profit Doctors for Equal Rights for People with Mental and Physical Pain.  Dr. Salerian also has been a reviewer of pain issues for the New England Journal of Medicine; an opinion leader for the FDA; a consultant to the FBI in numerous matters; a leader in performing transcranial magnetic stimulation; and a pioneer in neuroscience with scholarly contributions in peer reviewed journals.  Dr. Salerian has been at the forefront in discoveries relating to Alzheimer's and depression.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs